Accredited by FACT-NetCord
StemCord is a private cord blood bank in Singapore that is accredited by FACT-NetCord, a recognised and prestigious international accrediting organisation that is specific for cord blood banks. We are proud to have been awarded FACT-NetCord accreditation for the fourth time in 2011, 2014, 2017, 2021.
The FACT-NetCord accreditation for Cord Blood Collection, Processing, Testing, Banking, Selection and Release confirms StemCord’s firm reputation as a:
- Leader in the cord blood industry
- Company managed by medical professionals, constantly striving to achieve the highest international standard and quality of care and service for cord blood bank programmes.
- About FACT-NetCord
- Who Developed the FACT-NetCord Accreditation Programme?
- What Distinguishes a FACT-NetCord Accreditation from Others?
- Why Must You Choose A FACT-NetCord Accredited Cord Blood Bank?
Who Is FACT-NetCord?
FACT (Foundation for the Accreditation of Cellular Therapy) establishes and promotes comprehensive standards for quality patient care and laboratory performance in the belief that a valid accreditation should assess both clinical and laboratory aspects. The NetCord foundation is an international network of non-profit public cord blood banks created to promote the establishment of high-quality cord blood banks and improve the quality of cord blood products through study and research.
Recognising the global impact of cord blood banking and transplantation, FACT partnered with NetCord in 2000 to develop international standards for cord blood collection, processing, testing, banking, selection, and release. Today, FACT-NetCord stands as an established and a prestigious accrediting organisation specifically for cord blood banks.
Who developed the FACT-NetCord Accreditation Programme?
The FACT Inspection and Accreditation Programme was developed by Dr. Phyllis Warkentin, FACT Medical Director, the FACT Directors and Officers, as well as the International Society for Cellular Therapy (ISCT) and the American Society for Blood and Marrow Transplantation (ASBMT) Regulatory and Standards Committees. The first edition of the FACT-NetCord Standards was published in 2000.
What Distinguishes a FACT-NetCord Accreditation from Others?
FACT-NetCord is the only accrediting organisation that addresses all quality aspects of hematopoietic cell therapy (collection, processing, and transplantation). A FACT-NetCord accreditation is awarded after successful documentation/proof of compliance with the FACT-NetCord Standards. These Standards are developed by international teams of world-renowned experts in the field of Cellular Therapy. They include the only set of international requirements that encompass both clinical and laboratory practices, in believing that since quality can only be achieved if both clinical and laboratory issues are effectively addressed.FACT-NetCord is the all-but-necessary qualification to be accepted and competitive in the field of cellular therapy.
Why FACT-NetCord Accreditation
Banking your baby’s cord blood is a long-term commitment and it is important to bank with a cord blood bank of the highest quality standards. FACT NetCord Standards are defined by international teams of experts in the field of cellular therapy and are updated regularly through the collaboration and input of researchers and innovators who are responsible for advancing the field. Input from the wider transplant community and the public is actively sought.
FACT-NetCord, inspires confidence in doctors and patients as the only accrediting agency that addresses all quality aspects of cord blood collection, processing, testing, banking, selection and release.
StemCord voluntarily sought FACT-NetCord accreditation and went through a rigorous process, as we believe that quality care and practices are of paramount importance. StemCord continues to maintain FACT-NetCord accreditation so as to provide high quality services and cellular therapy products to patients and healthcare providers.
“Sometimes the strength of the motherhood is greater than natural laws.”Barbara Kingsolver